PMC:7386875 / 49609-49922 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T499","span":{"begin":87,"end":94},"obj":"Body_part"},{"id":"T500","span":{"begin":170,"end":177},"obj":"Body_part"},{"id":"T501","span":{"begin":230,"end":235},"obj":"Body_part"}],"attributes":[{"id":"A499","pred":"fma_id","subj":"T499","obj":"http://purl.org/sig/ont/fma/fma82839"},{"id":"A500","pred":"fma_id","subj":"T500","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A501","pred":"fma_id","subj":"T501","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Another interesting aspect of how the SARS-CoV-2 virus may be influenced by the use of heparin as anticoagulant is the previous observation that FXa can cleave the spike protein of SARS-CoV to render it more efficient in invading cells.147 However, to date, this aspect remains to be investigated with SARS-CoV-2."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T366","span":{"begin":38,"end":46},"obj":"Disease"},{"id":"T367","span":{"begin":181,"end":189},"obj":"Disease"},{"id":"T368","span":{"begin":302,"end":310},"obj":"Disease"}],"attributes":[{"id":"A366","pred":"mondo_id","subj":"T366","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A367","pred":"mondo_id","subj":"T367","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A368","pred":"mondo_id","subj":"T368","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Another interesting aspect of how the SARS-CoV-2 virus may be influenced by the use of heparin as anticoagulant is the previous observation that FXa can cleave the spike protein of SARS-CoV to render it more efficient in invading cells.147 However, to date, this aspect remains to be investigated with SARS-CoV-2."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T528","span":{"begin":49,"end":54},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T529","span":{"begin":230,"end":235},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Another interesting aspect of how the SARS-CoV-2 virus may be influenced by the use of heparin as anticoagulant is the previous observation that FXa can cleave the spike protein of SARS-CoV to render it more efficient in invading cells.147 However, to date, this aspect remains to be investigated with SARS-CoV-2."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T41445","span":{"begin":87,"end":94},"obj":"Chemical"},{"id":"T78519","span":{"begin":98,"end":111},"obj":"Chemical"},{"id":"T91720","span":{"begin":170,"end":177},"obj":"Chemical"}],"attributes":[{"id":"A62091","pred":"chebi_id","subj":"T41445","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A20724","pred":"chebi_id","subj":"T78519","obj":"http://purl.obolibrary.org/obo/CHEBI_50249"},{"id":"A24811","pred":"chebi_id","subj":"T91720","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Another interesting aspect of how the SARS-CoV-2 virus may be influenced by the use of heparin as anticoagulant is the previous observation that FXa can cleave the spike protein of SARS-CoV to render it more efficient in invading cells.147 However, to date, this aspect remains to be investigated with SARS-CoV-2."}

{"project":"LitCovid-sentences","denotations":[{"id":"T169","span":{"begin":0,"end":313},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Another interesting aspect of how the SARS-CoV-2 virus may be influenced by the use of heparin as anticoagulant is the previous observation that FXa can cleave the spike protein of SARS-CoV to render it more efficient in invading cells.147 However, to date, this aspect remains to be investigated with SARS-CoV-2."}

{"project":"2_test","denotations":[{"id":"32586214-19321428-21597819","span":{"begin":236,"end":239},"obj":"19321428"}],"text":"Another interesting aspect of how the SARS-CoV-2 virus may be influenced by the use of heparin as anticoagulant is the previous observation that FXa can cleave the spike protein of SARS-CoV to render it more efficient in invading cells.147 However, to date, this aspect remains to be investigated with SARS-CoV-2."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1663","span":{"begin":145,"end":148},"obj":"Gene"},{"id":"1664","span":{"begin":164,"end":169},"obj":"Gene"},{"id":"1665","span":{"begin":38,"end":48},"obj":"Species"},{"id":"1666","span":{"begin":181,"end":189},"obj":"Species"},{"id":"1667","span":{"begin":302,"end":312},"obj":"Species"},{"id":"1669","span":{"begin":87,"end":94},"obj":"Chemical"}],"attributes":[{"id":"A1663","pred":"tao:has_database_id","subj":"1663","obj":"Gene:2159"},{"id":"A1664","pred":"tao:has_database_id","subj":"1664","obj":"Gene:43740568"},{"id":"A1665","pred":"tao:has_database_id","subj":"1665","obj":"Tax:2697049"},{"id":"A1666","pred":"tao:has_database_id","subj":"1666","obj":"Tax:694009"},{"id":"A1667","pred":"tao:has_database_id","subj":"1667","obj":"Tax:2697049"},{"id":"A1669","pred":"tao:has_database_id","subj":"1669","obj":"MESH:D006493"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Another interesting aspect of how the SARS-CoV-2 virus may be influenced by the use of heparin as anticoagulant is the previous observation that FXa can cleave the spike protein of SARS-CoV to render it more efficient in invading cells.147 However, to date, this aspect remains to be investigated with SARS-CoV-2."}